Sentence examples for both trials were pooled from inspiring English sources

Due to the similar study designs of BLISS-52 and BLISS-76, data from both trials were pooled by treatment group for analyses in HRQOL measures.

Progression-free (PFS) or disease-free (DFS) as well as overall survival (OS) data from both trials were pooled and the HFSR group was compared with the non-HFSR using Kaplan Meier analysis.

Solanezumab failed to meet its primary outcome measure in Expedition 2. When data from both trials were pooled, then solanezumab therapy significantly improved cognitive performance as measured by ADAS-cog14, but this improvement was driven largely from the Expedition 1 result.

As the two phase III trials were similar in design and the primary endpoint was met in both, data across the trials were pooled in this post-hoc analysis to increase precision.

Data from the five pivotal trials were pooled for additional analyses, both across all five studies (n=2,119) and across the three CD studies (n=1,389) or 2 UC (n=730) studies due to similarities in study design and homogeneity of the patient populations.

146 manuscripts involving 182 clinical trials were pooled (n = 36,385).

InterMune said that when the results of its own two trials were pooled, pirfenidone reduced the risk of disease progression by about 25percentt.

Data from 3 trials were pooled to assess the efficacy and safety of efalizumab, a humanized monoclonal IgG1 antibody against the α-subunit (CD11a) of leukocyte function-associated antigen-1, in patients with moderate to severe plaque psoriasis.

Nancy Thornberry, who heads diabetes drug development at Merck, said that clinical trials, the gold standard of medical evidence, had found no increased risk of pancreatic disease from Januvia, even when results of trials were pooled to achieve greater numbers.

When data from all the 33 trials were pooled, telmisartan was associated with statistically significant reductions in percent changes of insulin levels (−10.92%; −15.60% to −6.23%; P < .00001) and HOMA-IR (−15.89%; −22.01% to −9.78%; P < .00001) relative to other antihypertensive drugs.

Five double-blind, randomized, controlled crossover trials were pooled.